Time trajectories of key cardiometabolic parameters and of cardiovascular risk in subjects with diabetes in a real world setting.


Journal

Diabetes & metabolic syndrome
ISSN: 1878-0334
Titre abrégé: Diabetes Metab Syndr
Pays: Netherlands
ID NLM: 101462250

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 20 05 2022
revised: 07 04 2023
accepted: 28 04 2023
medline: 19 6 2023
pubmed: 23 5 2023
entrez: 22 5 2023
Statut: ppublish

Résumé

Diabetes is associated with increased cardiovascular risk. Glycated haemoglobin (HbA We linked the diabetes electronic health records to the laboratory information system so as to investigate the trajectories of key metabolic parameters from 3 years prior to the diagnosis of diabetes to 10 years after diagnosis. We calculated the cardiovascular risk at the different time points during this period using the United Kingdom Prospective Study (UKPDS) risk engine. The study included 21,288 patients. The median age at diagnosis was 56 years and 55.3% were male. There was a sharp decrease in HbA Our data suggest that lipid control should be tightened with increasing duration of diabetes since this is more readily achievable than HbA

Sections du résumé

BACKGROUND AND AIMS OBJECTIVE
Diabetes is associated with increased cardiovascular risk. Glycated haemoglobin (HbA
METHODS METHODS
We linked the diabetes electronic health records to the laboratory information system so as to investigate the trajectories of key metabolic parameters from 3 years prior to the diagnosis of diabetes to 10 years after diagnosis. We calculated the cardiovascular risk at the different time points during this period using the United Kingdom Prospective Study (UKPDS) risk engine.
RESULTS RESULTS
The study included 21,288 patients. The median age at diagnosis was 56 years and 55.3% were male. There was a sharp decrease in HbA
CONCLUSIONS CONCLUSIONS
Our data suggest that lipid control should be tightened with increasing duration of diabetes since this is more readily achievable than HbA

Identifiants

pubmed: 37216853
pii: S1871-4021(23)00073-5
doi: 10.1016/j.dsx.2023.102777
pii:
doi:

Substances chimiques

Lipids 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102777

Informations de copyright

Copyright © 2023 Research Trust of DiabetesIndia (DiabetesIndia) and National Diabetes Obesity and Cholesterol Foundation (N-DOC). Published by Elsevier Ltd. All rights reserved.

Auteurs

Marie-Claire Fava (MC)

Mater Dei Hospital, Malta.

Sascha Reiff (S)

Department for Policy in Health, Malta.

Joseph Azzopardi (J)

University of Malta Medical School, Malta.

Stephen Fava (S)

Mater Dei Hospital, Malta; University of Malta Medical School, Malta. Electronic address: stephen.fava@um.edu.mt.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH